Menglu Han

Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy.

H. Lenz, A. Epstein, J. Lang, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity.

H. Lenz, Qinqin Cheng, Yong Zhang, 2018, Journal of the American Chemical Society.

Preclinical Evaluation of a Single Intravenous Infusion of hUC-MSC (BX-U001) in Rheumatoid Arthritis

Weian Zhao, Henry P. Farhoodi, Linan Liu, 2020, Cell transplantation.

Meta-analysis of preclinical studies of mesenchymal stromal cells to treat rheumatoid arthritis

Weian Zhao, Henry P. Farhoodi, Linan Liu, 2019, EBioMedicine.

Toward the design of a catalytic metallodrug: selective cleavage of G-quadruplex telomeric DNA by an anticancer copper-acridine-ATCUN complex.

Zhen Yu, J. Cowan, Menglu Han, 2015, Angewandte Chemie.